United States Food and Drug Administration Grants an Investigational Device Exemption for Compassionate Use of ReCell

The IDE granted by the US FDA allows ReCell to be evaluated clinically as an investigational device in subjects with life-threatening conditions requiring extensive skin grafting ReCell will be used to augment skin grafting for patients who have insuffi... Devices, Regenerative Medicine, FDAAvita Medical, ReCell, Spray-on Skin
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news